OMX-Solutions Ltd, an innovative medical technology company manufacturing and developing titanium 3D printed oral – maxillofacial implants and devices for challenging reconstructive surgery has signed a distribution agreement with Pacific Dental Specialities for the sales, support and promotion of their suite of products in New Zealand.
OMX Solutions is developing a suite of customized mandibular prosthesis and permanent implants as an alternative means of reconstruction products using advanced software and digital planning that will benefit patients and surgeons eliminating the morbidity and surgical challenges that current treatment presents.
Whilst OMX-Solutions has commenced export activities to India in 2018, this represents OMX first formal distribution and international partnership. Mick Shaddock GM for OMX said;
“OMX is very excited by this partnership and not just because it is our first formal sales partnership agreement. We recognize the potential that the partnership represents for both organizations to offer our solutions to New Zealand clinicians and patients. Pacific Dental Specialities are a highly regarded and recognized business and their expertise in the dental/oral maxillofacial clinical speciality area is highly regarded. Pacific Dental Specialities complimentary range of products including advanced digital scanning equipment, 3D printing systems and accessories provides a great synergy for our business. We look forward to supporting their endeavours and their customers in New Zealand”
Hyll Coraj commented that;
“The partnership offers fantastic synergy for both business and B2B opportunities between both organizations were already happening. Representing such a globally innovative company like OMX offers a real point of difference for our growing surgeon and hospital contact points and the offering sits comfortably in our portfolio of leading technology. Already there has been a number of enquires for the OMX service and we expect this to grow and translate into procedures and implant devices quite rapidly. We look forward to working with OMX for many years to come.”
About Pacific Dental Specialities:
Pacific Dental Specialties (PDS) was formed in August 2007. PDS is an Australasian independent dental supply company positioned to bring unique, innovative solutions to the Australasian market at the best market price. Each product is designed to make your dental procedures more efficient and cost effective. With a combination of years of management experience in the dental implant field, our philosophy was to source and market unique products that would benefit doctors, technicians and their staff during their dental implant experience. PDS offers the finest in surgical and restorative products sourced from the most reliable manufacturers and suppliers throughout the world.
PDS do not just sell products – we offer clients solutions. All our products are unique and are sourced to customer requests and feedback or gaps identified in the market. PDS is located in both Australia and New Zealand, allowing customers to receive timely service and support locally.
About OMX Solutions
OMX Solutions was established in early 2016 to commercialise a new TMJ Total Joint Replacement System as invented by the company founder, Dr George Dimitroulis.
The company embraced the 3D printing digital revolution, expanding upon its product range beyond the TMJ prosthesis and began to offer a broader range of oral and maxillofacial devices such as Custom Plates, Bio-models, custom surgical Splints and Guides. In addition to these, a brand-new implantable device, the Osseo-Frame™, began to take shape.
Since its inception, the company has rapidly expanded, thanks to government grants and support. OMX currently has over a dozen employees including interns. With the appointment of an experienced new general manager in October 2017, OMX is preparing for further expansion of the company. OMX goal is to be the world leader in the development of exciting new customized and personalized surgical products and devices that will become game-changers in Craniomaxillofacial surgery.